Skip to main content

Newsroom

Press Releases

October 6, 2017
GAITHERSBURG, Md., Oct. 06, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has completed its acquisition of Sanofi’s ACAM2000®, (Smallpox (Vaccinia) Vaccine, Live) business, which includes ACAM2000, the only smallpox vaccine approved by the U.S. Food and Dru...

 


Corporate Headquarters Ribbon Cutting

Media
Lynn R. Kieffer
kiefferl@ebsi.com 
TEL 240-631-3391 

Investors
Robert Burrows 
burrowsr@ebsi.com 
TEL 240-631-3280